Erschienen in:
Open Access
01.12.2020 | Correction
Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines
verfasst von:
Karolin Ebert, Gwen Zwingenberger, Elena Barbaria, Simone Keller, Corinna Heck, Rouven Arnold, Vanessa Hollerieth, Julian Mattes, Robert Geffers, Elba Raimúndez, Jan Hasenauer, Birgit Luber
Erschienen in:
BMC Cancer
|
Ausgabe 1/2020
Correction to: BMC Cancer 20, 1039 (2020)
https://doi.org/10.1186/s12885-020-07540-7
Following publication of the original article [
1], the authors reported an error in the labeling of Table
5. The corrected Table
5 is given below.
Table 5
Candidate genes involved in phenotypic response to afatinib treatment
a) Genes potentially involved in reduction of motility after afatinib treatment |
SERPINE1 HBEGF | F3 ITGA2 | CXCL8 HAS2 | PLPP3 SPRY2 | F2RL1 | PTGS2 | CYR61 | CXCL1 | SEMA6D | ETS1 |
b) Genes potentially involved in induction of apoptosis after afatinib treatment |
BAX | BBC3 | BCLAF1 | CAV1 | E2F1 | FADD | FAF1 | FAS | GSN | HYAL2 |
IL19 | IL20RA | INHBB | LCK | LGALS9 | NACC2 | NF1 | NFATC4 | NKX3–1 | PAK2 |
PARK7 | PDCD5 | PDIA3 | PEA15 | PPIF | PPP2R1B | PPP3CC | PRKRA | SFN | SFPQ |
SKIL | SLC9A3R1 | SMAD3 | STK4 | TGFBR1 | TP73 | TPD52L1 | YWHAB | YWHAE | YWHAG |
YWHAH | YWHAQ | YWHAZ | ZNF205 | | | | | | |
The original article [
1] has been corrected.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.